Your browser doesn't support javascript.
loading
Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
Creemers, Sara G; Feelders, Richard A; de Jong, Frank H; Franssen, Gaston J H; de Rijke, Yolanda B; van Koetsveld, Peter M; Hofland, Leo J.
Afiliação
  • Creemers SG; Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands.
  • Feelders RA; Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands.
  • de Jong FH; Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands.
  • Franssen GJH; Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands.
  • de Rijke YB; Department of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands.
  • van Koetsveld PM; Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands.
  • Hofland LJ; Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands.
J Clin Endocrinol Metab ; 104(8): 3437-3449, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31127821
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Síndrome de Cushing / Inibidores Enzimáticos / Imidazóis Limite: Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Síndrome de Cushing / Inibidores Enzimáticos / Imidazóis Limite: Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos